Evaluation of the salivary level of glutathione reductase, catalase and free thiol in patients with oral lichen planus.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
09 08 2023
Historique:
received: 04 03 2023
accepted: 19 07 2023
medline: 11 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: epublish

Résumé

Oral lichen planus (OLP) is a usual chronic inflammatory disease of the oral mucosa with malignant capacity, whose pathogenesis is not yet well known. Free radicals and reactive oxygen species may have a vital role in the pathogenesis of oral lichen planus. This study aimed to assess Glutathione reductase, catalase, and free thiol levels in the saliva of OLP patients and compare it with healthy people. In this cross-sectional study, 35 patients with OLP and 20 healthy people were involved. Five mL of whole, unstimulated saliva samples were collected in the morning, and the salivary levels of antioxidants were measured by ELISA technique. In this experiment, sex, age and OLP types were also evaluated. There was a significant decrease in the patients' salivary level of Glutathione reductase (0.2043 mU/ml in patients and 0.3901 mU/ml in the control group) and catalase (0.1525 mU/ml in patients and 0.2700 mU/ml in the control group) (p = 0.001). But there were no differences between the two groups regarding free-thiol levels (0.0586 mU/ml in patients and 0.0569 mU/ml in the control group) (p = 0.7). However, there was no correlation between age and gender with the antioxidants' contents. There was a significant decrease in glutathione reductase and catalase in the erosive type than in the non-erosive type. In this study, we found that the salivary levels of Glutathione reductase and Catalase were lower in OLP patients than in the healthy group, which means these antioxidants were affected by OLP and also associated with the type of it. So salivary Glutathione reductase and Catalase levels may be used as biomarkers for OLP monitoring and treatment.

Identifiants

pubmed: 37559066
doi: 10.1186/s12903-023-03242-1
pii: 10.1186/s12903-023-03242-1
pmc: PMC10413704
doi:

Substances chimiques

Catalase EC 1.11.1.6
Glutathione Reductase EC 1.8.1.7
Antioxidants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

547

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Anal Biochem. 2000 Aug 1;283(2):214-21
pubmed: 10906242
Indian J Dermatol. 2015 May-Jun;60(3):222-9
pubmed: 26120146
Indian J Dermatol. 2022 Nov-Dec;67(6):651-656
pubmed: 36998886
Arch Oral Biol. 2013 Sep;58(9):1057-69
pubmed: 23660124
Acta Dermatovenerol Alp Pannonica Adriat. 2010;19(1):3-11
pubmed: 20372767
Biochim Biophys Acta. 2013 May;1830(5):3217-66
pubmed: 23036594
J Dermatol. 2002 Jul;29(7):399-403
pubmed: 12184635
J Can Dent Assoc. 2002 Sep;68(8):494-9
pubmed: 12323106
Biomed Pharmacother. 2005 Aug;59(7):365-73
pubmed: 16081237
Biol Chem. 2002 Mar-Apr;383(3-4):649-62
pubmed: 12033454
Pathol Res Pract. 2023 Aug;248:154569
pubmed: 37285732
Eur J Surg Oncol. 1999 Oct;25(5):520-3
pubmed: 10527601
Pharmacogn Rev. 2010 Jul;4(8):118-26
pubmed: 22228951
Contemp Clin Dent. 2013 Apr;4(2):181-5
pubmed: 24015006
Br J Oral Maxillofac Surg. 2008 Jan;46(1):15-21
pubmed: 17822813
Biomed Res Int. 2021 Feb 24;2021:8627435
pubmed: 33708994
Nat Med. 2004 Nov;10(11):1200-7
pubmed: 15489859
Dig Dis Sci. 2007 Sep;52(9):2015-21
pubmed: 17404859
Free Radic Biol Med. 2000 Feb 15;28(4):625-35
pubmed: 10719244
Biomed Res Int. 2022 Jun 1;2022:8100352
pubmed: 35692588
Acta Odontol Scand. 2001 Jun;59(3):174-7
pubmed: 11501887
Arch Biochem Biophys. 1990 Jul;280(1):1-8
pubmed: 2191627
Cell Mol Life Sci. 2004 Jan;61(2):192-208
pubmed: 14745498
Clin Exp Dermatol. 2007 Jul;32(4):430-4
pubmed: 17459065
Blood. 1996 Feb 15;87(4):1595-9
pubmed: 8608252
J Dermatol. 2003 Feb;30(2):104-8
pubmed: 12692376
J Cancer Res Ther. 2010 Jul-Sep;6(3):278-81
pubmed: 21119253
J Oral Pathol Med. 2012 Aug;41(7):524-6
pubmed: 22530656
Med Princ Pract. 2017;26(1):57-60
pubmed: 27694755
J Contemp Dent Pract. 2005 Nov 15;6(4):46-53
pubmed: 16299606

Auteurs

Fahimeh Rezazadeh (F)

Dept. of Oral and Maxillofacial Medicine, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Dorsa Mahdavi (D)

Student research committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Nima Fassihi (N)

Student research committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Hossein Sedarat (H)

Undergraduate medical Student, Jahrom University of Medical Sciences, Jahrom, Iran.

Elham Tayebi Khorami (E)

Student research committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran. etayebi@sums.ac.ir.

Amir Tabesh (A)

Student research committee, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH